In the ever-evolving landscape of treatments for joint and cartilage issues, patients today have access to a range of non-surgical options designed to alleviate pain and improve mobility. Among these, Cingal and Monovisc stand out as leading choices for those seeking relief from the discomforts of osteoarthritis and similar conditions. This article delves into the distinctions between Cingal and Monovisc, providing essential insights to help you understand which treatment may best suit your needs.
Cingal is a pioneering treatment that combines hyaluronic acid (HA) with corticosteroids to offer immediate and sustained relief from joint pain. The HA component works by restoring the natural lubrication of the joint, facilitating smoother movement, while the corticosteroid quickly reduces inflammation and pain. This dual-action formula makes Cingal a compelling option for those seeking fast and long-lasting relief.
Monovisc, on the other hand, is a pure hyaluronic acid-based treatment designed to mimic the natural lubricating fluid in the joint. It’s particularly favoured for its long-lasting lubrication effect, which can significantly reduce pain and improve joint functionality over time. Monovisc is a single-injection treatment, making it a convenient option for patients looking for a minimal intervention with enduring benefits.
Both Cingal and Monovisc are primarily used to treat pain associated with osteoarthritis, especially in the knee. However, they can also be effective in other joints afflicted by arthritis or related conditions.
Who Are the Candidates?
Candidates for either Cingal or Monovisc include individuals experiencing joint pain and mobility issues due to osteoarthritis, who have not responded adequately to traditional treatments such as physical therapy, oral medications, or other types of injections.
Cingal’s effects can last for up to six months, with immediate pain relief from the corticosteroid component. Monovisc also offers up to six months of relief, primarily through improved joint lubrication.
Both treatments can cause temporary injection site reactions such as pain, swelling, or bruising. Cingal, due to its corticosteroid component, may have additional considerations for those with specific health conditions.
Most patients can return to their regular activities within a few days following the injection, although it’s advised to avoid strenuous activities for a short period.
Neither treatment can cure osteoarthritis, but both can significantly reduce symptoms and improve quality of life.
The choice depends on your specific condition, severity of symptoms, and personal preferences. Consulting with an orthopaedic specialist is essential to make an informed decision.
Coverage varies, so it’s important to check with your insurance provider. Many insurers cover HA treatments for osteoarthritis under specific conditions.
In conclusion, both Cingal and Monovisc offer effective relief for those suffering from the pain and mobility issues associated with osteoarthritis, with each having its unique benefits. By understanding the differences and consulting with your healthcare provider, you can choose the treatment that best aligns with your health needs and lifestyle. At the London Cartilage Clinic, we’re dedicated to providing advanced, patient-centered care to help you achieve optimal joint health and a better quality of life.
Cartilage
Knees
Hip
Shoulder
